These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35377796)

  • 1. Gain of function due to increased opening probability by two
    Nappi M; Barrese V; Carotenuto L; Lesca G; Labalme A; Ville D; Smol T; Rama M; Dieux-Coeslier A; Rivier-Ringenbach C; Soldovieri MV; Ambrosino P; Mosca I; Pusch M; Miceli F; Taglialatela M
    Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2116887119. PubMed ID: 35377796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic and functional assessment of two novel KCNQ2 gain-of-function variants Y141N and G239S and effects of amitriptyline treatment.
    Bayat A; Iavarone S; Miceli F; Jakobsen AV; Johannesen KM; Nikanorova M; Ploski R; Szymanska K; Flamini R; Cooper EC; Weckhuysen S; Taglialatela M; Møller RS
    Neurotherapeutics; 2024 Jan; 21(1):e00296. PubMed ID: 38241158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced axonal surface expression and phosphoinositide sensitivity in K
    Kim EC; Zhang J; Pang W; Wang S; Lee KY; Cavaretta JP; Walters J; Procko E; Tsai NP; Chung HJ
    Neurobiol Dis; 2018 Oct; 118():76-93. PubMed ID: 30008368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss-of-Function and Gain-of-Function Mutations in KCNQ5 Cause Intellectual Disability or Epileptic Encephalopathy.
    Lehman A; Thouta S; Mancini GMS; Naidu S; van Slegtenhorst M; McWalter K; Person R; Mwenifumbo J; Salvarinova R; ; ; Guella I; McKenzie MB; Datta A; Connolly MB; Kalkhoran SM; Poburko D; Friedman JM; Farrer MJ; Demos M; Desai S; Claydon T
    Am J Hum Genet; 2017 Jul; 101(1):65-74. PubMed ID: 28669405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early-onset epileptic encephalopathy caused by gain-of-function mutations in the voltage sensor of Kv7.2 and Kv7.3 potassium channel subunits.
    Miceli F; Soldovieri MV; Ambrosino P; De Maria M; Migliore M; Migliore R; Taglialatela M
    J Neurosci; 2015 Mar; 35(9):3782-93. PubMed ID: 25740509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes.
    Mosca I; Rivolta I; Labalme A; Ambrosino P; Castellotti B; Gellera C; Granata T; Freri E; Binda A; Lesca G; DiFrancesco JC; Soldovieri MV; Taglialatela M
    Front Pharmacol; 2022; 13():872645. PubMed ID: 35770094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human
    Wei AD; Wakenight P; Zwingman TA; Bard AM; Sahai N; Willemsen MH; Schelhaas HJ; Stegmann APA; Verhoeven JS; de Man SA; Wessels MW; Kleefstra T; Shinde DN; Helbig KL; Basinger A; Wagner VF; Rodriguez-Buritica D; Bryant E; Millichap JJ; Millen KJ; Dobyns WB; Ramirez JM; Kalume FK
    J Neurophysiol; 2022 Jul; 128(1):40-61. PubMed ID: 35583973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epileptic channelopathies caused by neuronal Kv7 (KCNQ) channel dysfunction.
    Nappi P; Miceli F; Soldovieri MV; Ambrosino P; Barrese V; Taglialatela M
    Pflugers Arch; 2020 Jul; 472(7):881-898. PubMed ID: 32506321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The KCNQ5 potassium channel mediates a component of the afterhyperpolarization current in mouse hippocampus.
    Tzingounis AV; Heidenreich M; Kharkovets T; Spitzmaul G; Jensen HS; Nicoll RA; Jentsch TJ
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10232-7. PubMed ID: 20534576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kv7.3 Compound Heterozygous Variants in Early Onset Encephalopathy Reveal Additive Contribution of C-Terminal Residues to PIP
    Ambrosino P; Freri E; Castellotti B; Soldovieri MV; Mosca I; Manocchio L; Gellera C; Canafoglia L; Franceschetti S; Salis B; Iraci N; Miceli F; Ragona F; Granata T; DiFrancesco JC; Taglialatela M
    Mol Neurobiol; 2018 Aug; 55(8):7009-7024. PubMed ID: 29383681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recurrent KCNQ2 pore mutation causing early onset epileptic encephalopathy has a moderate effect on M current but alters subcellular localization of Kv7 channels.
    Abidi A; Devaux JJ; Molinari F; Alcaraz G; Michon FX; Sutera-Sardo J; Becq H; Lacoste C; Altuzarra C; Afenjar A; Mignot C; Doummar D; Isidor B; Guyen SN; Colin E; De La Vaissière S; Haye D; Trauffler A; Badens C; Prieur F; Lesca G; Villard L; Milh M; Aniksztejn L
    Neurobiol Dis; 2015 Aug; 80():80-92. PubMed ID: 26007637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization and in vitro pharmacological rescue of KCNQ2 pore mutations associated with epileptic encephalopathy.
    Yang GM; Tian FY; Shen YW; Yang CY; Yuan H; Li P; Gao ZB
    Acta Pharmacol Sin; 2023 Aug; 44(8):1589-1599. PubMed ID: 36932231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-limited alterations in cortical activity of a knock-in mouse model of KCNQ2-related developmental and epileptic encephalopathy.
    Biba-Maazou N; Becq H; Pallesi-Pocachard E; Sarno S; Granjeaud S; Montheil A; Kurz M; Villard L; Milh M; Santini PL; Aniksztejn L
    J Physiol; 2022 May; 600(10):2429-2460. PubMed ID: 35389519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine.
    Schenzer A; Friedrich T; Pusch M; Saftig P; Jentsch TJ; Grötzinger J; Schwake M
    J Neurosci; 2005 May; 25(20):5051-60. PubMed ID: 15901787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heteromeric Assembly of Truncated Neuronal Kv7 Channels: Implications for Neurologic Disease and Pharmacotherapy.
    Li J; Maghera J; Lamothe SM; Marco EJ; Kurata HT
    Mol Pharmacol; 2020 Sep; 98(3):192-202. PubMed ID: 32580997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo SCN8A and inherited rare CACNA1H variants associated with severe developmental and epileptic encephalopathy.
    Stringer RN; Jurkovicova-Tarabova B; Souza IA; Ibrahim J; Vacik T; Fathalla WM; Hertecant J; Zamponi GW; Lacinova L; Weiss N
    Mol Brain; 2021 Aug; 14(1):126. PubMed ID: 34399820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Kv7.3 Variant in the Voltage-Sensing S
    Miceli F; Carotenuto L; Barrese V; Soldovieri MV; Heinzen EL; Mandel AM; Lippa N; Bier L; Goldstein DB; Cooper EC; Cilio MR; Taglialatela M; Sands TT
    Front Physiol; 2020; 11():1040. PubMed ID: 33013448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss-of-function variants in the KCNQ5 gene are implicated in genetic generalized epilepsies.
    Krüger J; Schubert J; Kegele J; Labalme A; Mao M; Heighway J; Seebohm G; Yan P; Koko M; Aslan-Kara K; Caglayan H; Steinhoff BJ; Weber YG; Keo-Kosal P; Berkovic SF; Hildebrand MS; Petrou S; Krause R; May P; Lesca G; Maljevic S; Lerche H
    EBioMedicine; 2022 Oct; 84():104244. PubMed ID: 36088682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy.
    Soldovieri MV; Freri E; Ambrosino P; Rivolta I; Mosca I; Binda A; Murano C; Ragona F; Canafoglia L; Vannicola C; Solazzi R; Granata T; Castellotti B; Messina G; Gellera C; Labalme A; Lesca G; DiFrancesco JC; Taglialatela M
    Pharmacol Res; 2020 Oct; 160():105200. PubMed ID: 32942014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological and pharmacological characterization of a novel and potent neuronal Kv7 channel opener SCR2682 for antiepilepsy.
    Zhang F; Liu Y; Tang F; Liang B; Chen H; Zhang H; Wang K
    FASEB J; 2019 Aug; 33(8):9154-9166. PubMed ID: 31063701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.